drugset / Trial / NCT03183505
Comparison of Anyu Peibo With Placebo in Treatment of MDD,Ⅱb
Phase 2
Completed
172 enrolled
Shanghai Mental Health Center
Su Zhou YiHua Biotechnology Co. LTD · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of Anyu Peibo Capsule comparing with placebo in the treatment of Chinese Patients with Depression. And to provide some scientific evidence for protocol designing in following phase Ⅲ clinical trial.
Timeline
- Start
- 2017-06-30
- Primary completion
- 2018-10-05
- Completion
- 2018-11-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anyu Peibo | Unknown | 0.8 g | Oral |